REGENALL DIAGNOSTICS LIMITED

**REGENALL DIAGNOSTICS LIMITED** is an active private limited company incorporated on 13 February 2025 under the jurisdiction of England and Wales. The company is registered at 19 Harley Street, London, W1G 9QJ, and its principal activity is classified under SIC code 86900.

It is currently in good standing with no charges, no insolvency history, and no overdue filing obligations. The next accounts are due by 13 November 2026, and the next confirmation statement is due by 26 February 2027. The most recent confirmation statement, made up to 12 February 2026, was filed on 11 May 2026 with no updates.

The board comprises three British directors, all appointed on incorporation: Professor Christopher Brian Dyce Lavy, Nicola Karina Christina Horlick, and Professor Roger Kenneth Whealands Smith, all resident in England.

Significant control rests with two individuals. Hilali Mohamed Hamza Noordeen holds 50–75% of the shares and voting rights and the right to appoint and remove directors. Mohamed Hamza Hilali Idroos Noordeen holds 25–50% of the shares and voting rights. Both have held their positions since incorporation. A PSC04 filing was submitted on 11 May 2026 reflecting a change to a person with significant control.